CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM NO PAR
Total 13F shares
5,795,877
Share change
+454,767
Total reported value
$51,747,000
Price per share
$8.93
Number of holders
26
Value change
+$4,366,628
Number of buys
10
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q3 2014

As of 30 Sep 2014, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,795,877 shares. The largest 10 holders included FMR LLC, Fortress Investment Group LLC, ADAGE CAPITAL PARTNERS GP LLC, PUTNAM INVESTMENTS LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, CLOUGH CAPITAL PARTNERS L P, TURNER INVESTMENTS, L.P., RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and ROYAL BANK OF CANADA. This page lists 26 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.